Brief: CENTOGENE Expands Partnership With Agios To Generate Novel Insights Into Rare Blood Diseases
Nov 4 (Reuters) - Centogene NV 39K.MU :
* CENTOGENE EXPANDS PARTNERSHIP WITH AGIOS TO GENERATE NOVEL
INSIGHTS INTO RARE BLOOD DISEASES
* CENTOGENE NV - UNDER NEW AGREEMENT, CO TO PROVIDE GENETIC
TESTING, CLINICAL TRIAL SUPPORT FOR AGIOS' THREE TRIALS IN
THALASSEMIA, SICKLE CELL DISEASE
* CENTOGENE NV - COMPANIES SIGNED A COMMERCIAL THREE-YEAR
FEE-FOR-SERVICE AGREEMENT
* CENTOGENE NV - AGIOS WILL BE COORDINATING AND BEARING
COSTS FOR
PROGRAMS
* CENTOGENE NV - FURTHER FINANCIAL DETAILS WERE NOT
DISCLOSED
Source text for Eikon: ID:nGNX58WzTB
Further company coverage: 39K.MU
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crown LiquidationCo NV in liquidatie
See all newsBrief: Centogene Signs Strategic Transaction With Private Equity Group Charme Capital Partners
Brief: Centogene Announces Adoption Of All Resolutions Tabled At 2024 Annual General Meeting
Brief: Centogene NV Says Agreements With LIFERA Provides Funding In Aggregate Of About $20 Mln To Co
Brief: Centogene And Evotec Discover Promising New Molecule To Treat Gaucher Disease
Brief: Centogene Receives Nasdaq Non-Compliance Notice